Submitted by Anonymous (not verified) on 14 May 2024 - 17:00
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 May 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 May 2024 to 16 May 2024
Source:
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 May 2024, European Medicines Agency, Amsterdam, the Netherlands, from 13 May 2024 to 16 May 2024